(Q46421937)
Statements
Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses (English)
Graham Pawelec
Jürgen C Becker
Benjamin Weide
Annette Pflugfelder
Leonardo Giovannoni
Henning Zelba
Alexander Martens
1 reference